• OPEN AN ACCOUNT
Indian Indices
Nifty
16,259.30 417.00
(2.63%)
Sensex
54,318.47 1,344.63
( 2.54%)
Bank Nifty
34,301.90 704.30
( 2.10%)
Nifty IT
30,218.70 815.20
( 2.77%)
Global Indices
Nasdaq
11,662.79 -142.21
(-1.20%)
Dow Jones
32,223.42 26.76
(0.08%)
Hang Seng
20,602.52 652.31
(3.27%)
Nikkei 225
26,659.75 112.70
(0.42%)
Forex
USD-INR
77.57 0.37
(0.48%)
EUR-INR
80.81 0.56
(0.70%)
GBP-INR
95.15 0.82
(0.87%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Sun Pharmaceuticals Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
113.4726657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
122.7
214032.68
EPS(TTM)
Face Value()
Div & Yield %
7.27
1
0.84
 

As on: As on: May 18, 2022 05:32 AM

Last Price() Net Change (%) Volume (Nos) P / E
892.05 6.30 49785 122.70
Stock Price Details
Open Price() 882.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 895.70
Today's Low () 878.60
52-Week High () 966.9
152-Week Low () 652.75
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.84
Eps 7.27
Book Value 113.4726657
Market Cap (.Cr) 214,032.68
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date Aug
ISIN No. INE044A01036


News
Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
Sun Pharma gets USFDA approval for generic Mesalamine capsules
Sun Pharmaceuticals Industries to conduct board meeting
Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
Sun Pharma's Halol facility concludes USFDA audit with 10 observations
Sun Pharma slips after Halol unit gets 10 observations from US FDA
Sun Pharmaceuticals Industries Ltd - Disclosure Under Regulation 30
Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
Sun Pharmaceuticals Industries Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Sun Pharmaceuticals Industries Ltd - Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
More
Corporate Details
Incoporation Year   : 1993
Chairman : Israel Makov
Bussiness Group : Sun Pharma
Registered Office
Sun Pharmaceuticals Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-265-6615500
Fax:91-265-2354897
Fax:91-22-66317458
E-Mail : secretarial@sunpharma.com
URL : http://www.sunpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE SENSEX
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE GREENEX
  • bse carbonex
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • NI15 Index
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi